文献

J-GLOBAL ID：201602226571482820   整理番号：16A0764359

乾癬皮膚におけるCCR9発現量の増加は,インフリキシマブ治療に対する悪い臨床結果と関係する

Enhanced CCR9 expression levels in psoriatic skin are associated with poor clinical outcome to infliximab treatment

著者 (10件)： Koga Aiko (Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan) ,  Kajihara Ikko (Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan) ,  Yamada Saori (Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan) ,  Makino Katsunari (Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan) ,  Ichihara Asako (Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan) ,  Aoi Jun (Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan) ,  Makino Takamitsu (Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan) ,  Fukushima Satoshi (Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan) ,  Jinnin Masatoshi (Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan) ,  Ihn Hironobu (Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan)
資料名： Journal of Dermatology  (Journal of Dermatology)
巻： 43  号： 5  ページ： 522-525  発行年： 2016年05月 
JST資料番号： W1578A  ISSN： 0385-2407  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： オーストラリア (AUS)  言語： 英語 (EN)

抄録/ポイント： インフリキシマブは,腫瘍壊死因子(TNF)-αおよびその関連...

シソーラス用語： *乾癬 ,...
準シソーラス用語： *CCR9 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A0764359&from=J-GLOBAL&jstjournalNo=W1578A") }}

著者キーワード (5件)： CCR9 ,  chemokine ,  clinical outcome ,  infliximab ,  psoriasis

分類 (3件)： 皮膚の診断  (GF02000J) ,  細胞膜の受容体  (EF04030C) ,  免疫療法薬・血液製剤の基礎研究  (GW22010D)

引用文献 (26件)：

• Nestle FO, Di Meglio P, Qin JZ et al. Skin immune sentinels in health and disease. Nat Rev Immunol 2009; 9: 679-691.
• Zaba LC, Cardinale I, Gilleaudeau P et al. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med 2007; 204: 3183-3194.
• Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Eng J Med 2006; 354: 610- 621.
• Mabuchi T, Chang TW, Quinter S et al. Chemokine receptors in the pathogenesis and therapy of psoriasis. J Dermatol Sci 2012; 65 (1): 4-11.
• Rottman JB, Smith TL, Ganley KG et al. Potential role of the chemokine receptors CXCR3, CCR4, and the integrin αEβ7 in the pathogenesis of psoriasis vulgaris. Lab Invest 2001; 81: 335-347.

タイトルに関連する用語 (7件)： 乾癬 ,  皮膚 ,  CCR9 ,  発現 ,  インフリキシマブ ,  治療 ,  臨床